%0 Journal Article
%T A Study on Pulmonary Tuberculosis and Risk Factors in New and Re-Treated Presumptive Patients at Wad Madani Tuberculosis Center, Sudan (2018-2019): A Cross-Sectional Study
%A Zeinab H. Alfaham
%A Elhadi A. Ahmed
%A Elamin M. Ibrahim
%A Mohamed Soud Mohamed
%A Ameer A. Mohamed
%A Ayman Mahjob
%A Mubarak A. Elshafia
%A Bakri Y. M. Nour
%J Journal of Tuberculosis Research
%P 18-27
%@ 2329-8448
%D 2022
%I Scientific Research Publishing
%R 10.4236/jtr.2022.101002
%X </span><b><span style=\"font-family:Verdana;\">Introduction:</span></b><span style=\"font-family:Verdana;\">&lt;/b&gt; The increase
in cases of drug-resistant pulmonary tuberculo</span></span></span><span><span><span style=\"font-family:&quot;\"><span style=\"font-family:Verdana;\">sis, especially in endemic areas, is mainly associated with re-treatment,
although resistant tubercle bacilli can be easily transmitted between all
susceptible persons.</span><b> </b><span style=\"font-family:Verdana;\">&lt;b&gt;</span><b><span style=\"font-family:Verdana;\">Objective:</span></b><span style=\"font-family:Verdana;\">&lt;/b&gt;</span><b> </b><span style=\"font-family:Verdana;\">The study aimed to describe
pulmonary tuberculosis, risk factors and MDR in new and re-treated suspected
patients attending Wad Madani Tuberculosis Center that provides service in
central </span><span style=\"font-family:Verdana;\">Sudan</span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">.</span></span></span><span><span><span style=\"font-family:&quot;\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">&lt;b&gt;</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><b><span style=\"font-family:Verdana;\">Methods:</span></b></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">&lt;/b&gt;</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> Cross-sectional laboratory
based study among 300 presu</span></span></span><span><span><span style=\"font-family:&quot;\"><span style=\"font-family:Verdana;\">mptive pulmonary tuberculosis patients during 2018
and 2019 was conducted.</span><b> </b><span><span style=\"font-family:Verdana;\">Cases were
divided into new and re-treated. &lt;i&gt;</span><i><span style=\"font-family:Verdana;\">Mycobacterium tuberculosis</span></i><span style=\"font-family:Verdana;\">&lt;/i&gt;</span><span style=\"font-family:Verdana;\"> D</span></span><span style=\"font-family:Verdana;\">NA and rpoB gene
of multi-drug resistance (MDR) were detected in sputum samples by GeneXpert
assay as manufacturer instructions. </span><span style=\"font-family:Verdana;\">&lt;b&gt;</span><b><span style=\"font-family:Verdana;\">Results:</span></b><span style=\"font-family:Verdana;\">&lt;/b&gt;</span><span style=\"font-family:Verdana;\">
%K MDR
%K Pulmonary Tuberculosis
%K Relapse
%K Sudan
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=115700